OBI Pharma Cash Flow Reinvestment Rate
Latest as of June 2013:
0.12x
OBI Pharma cash flow reinvestment rate. OBI Pharma (4174) has a Cash Flow Reinvestment Rate of 0.12x as of June 2013, reinvesting NT$5.80 Million (capex NT$5.80 Million ) from operating cash flow of NT$50.26 Million. Explore OBI Pharma debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.12x
(Capex + Investments) / Operating CF
Total Reinvested
NT$5.80 Million
Capex + Investments
Operating Cash Flow
NT$50.26 Million
TWD
Capital Expenditures
NT$5.80 Million
TWD
OBI Pharma Cash Flow Reinvestment Rate by Year (None–None)
OBI Pharma cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for OBI Pharma. For the full cash flow conversion analysis, see OBI Pharma (4174) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow